You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 290 No. 12, September 24, 2003 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Oncology
 •Breast Cancer
 •Lung Cancer
 •Prostate Cancer
 •Patient-Physician Relationship/ Care
 •End-of-life Care/ Palliative Medicine
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Hospice Use in Medicare Beneficiaries With Cancer—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: We agree with Dr Gagnon that not all patients diagnosed as having cancer should be considered terminally ill from it. Gagnon also notes that hospice use for patients with breast cancer was less than that of patients with lung cancer and suggests that this difference is because of the higher likelihood that patients with breast cancer die from other causes.

We did not suggest that patients dying of breast cancer had less access to hospice than patients with prostate or lung cancer. Indeed, when we restrict our analysis to patients who died from cancer, as ascertained by cause of death, 28.9% of patients with breast cancer, 30.1% of patients with lung cancer, and 31.8% of patients with prostate cancer received hospice care before death.

The focus of our study was differences in hospice use and length of stay in hospice between patients with Medicare managed care insurance vs . . . [Full Text of this Article]

Ellen P. McCarthy, PhD, MPH; Russell S. Phillips, MD
Department of General Medicine and Primary Care
Beth Israel Deaconess Medical Center
Boston, Mass



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Hospice Use in Medicare Beneficiaries With Cancer
Bruno Gagnon
JAMA. 2003;290(12):1578.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Identification in Administrative Databases of Women Dying of Breast Cancer
Gagnon et al.
JCO 2006;24:856-862.
ABSTRACT | FULL TEXT  

Palliative Care Inpatient Service in a Comprehensive Cancer Center: Clinical and Financial Outcomes
Elsayem et al.
JCO 2004;22:2008-2014.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.